BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 12, 2016
View Archived Issues
Otsuka tuberculosis candidate granted U.S. orphan drug designation
Read More
DynPort Vaccine Company plague vaccine granted FDA orphan drug status
Read More
Neutralizing human MAbs protect against infection and maternal-fetal transmission of ZIKV in vivo
Read More
Ortho-McNeil-Janssen Pharmaceuticals and KU Leuven patent dengue viral replication inhibitors
Read More
Roche and Genentech disclose ERalpha ligands
Read More
Cardiome Pharma launches Xydalba in U.K.
Read More
FDA accepts durvalumab BLA for urothelial cancer
Read More
GlaxoSmithKline describes KMO inhibitors
Read More
3D microtissue engineering used to generate hypertrophic cardiomyopathy cardiomyocytes
Read More
Soligenix reports long-term follow-up data from phase II trial of SGX-942 for oral mucositis
Read More
New U.K. alliance established to accelerate development of treatments for arthritis
Read More
SNPs in BDNF and GSK-3beta may be associated with bipolar disorder
Read More
AstraZeneca initiates phase I study of abediterol and AZD-7594
Read More
E2F4 activation shows promise for SCI recovery
Read More
Phase III trials show no benefit in adding Fovista to Lucentis for wet AMD
Read More
New MGL inhibitor shows promise for the treatment of pain
Read More
Valeant Pharmaceuticals reports positive results from phase III study of IDP-118
Read More
Synergy reports results from first phase III trial of plecanatide for IBS-C
Read More
BioInvent terminates phase II study of BI-505 in multiple myeloma
Read More
New phase I trial explores use of PGT-121 for HIV prevention and therapy
Read More
Seattle Genetics initiates phase I trial of SGN-CD352A in relapsed or refractory multiple myeloma
Read More
